Digital psychosocial intervention for older adults with depression

Conditions

Depression

Scazufca M, Nakamura CA, Seward N, Didone TVN, Moretti FA, Oliveira da Costa M, Queiroz de Souza CH, Macias de Oliveira G, Souza Dos Santos M, Pereira LA, Mendes de Sá Martins M, van de Ven P, Hollingworth W, Peters TJ, Araya R.

2024-03-1412 citations

10.1038/s41591-024-02864-4

Digital psychosocial intervention for depression among older adults in socioeconomically deprived areas in Brazil (PRODIGITAL-D): protocol for an individually randomised controlled trial.

Nakamura CA, Scazufca M, Moretti FA, Didone TVN, de Sá Martins MM, Pereira LA, de Souza CHQ, de Oliveira GM, da Costa MO, Machado M, da Silva Bitencourt E, Dos Santos MS, Murdoch J, van de Ven P, Seward N, Hollingworth W, Peters TJ, Araya R.

2022-09-077 citations

10.1186/s13063-022-06623-z

Interventions

Participants will receive automated messages through the WhatsApp Business application according to the allocation group. Participants will also receive messages on their mobile phones advising them t

F04.754.715

Eligibility

Age

60 Years to No maximum

Inclusion criteria

Inclusion criteria: Registered with one of the participating clinics or organisations; aged 60 or over; scores of PHQ-2=1 (first two questions of PHQ-9) and PHQ-9=10; able to receive live calls and WhatsApp messages (audio and images) on a mobile phone.

Exclusion criteria

Exclusion criteria: Unable to communicate (non-Portuguese speaking, cognitively impaired or other problem hindering communication to engage in trial assessment and intervention such as vision or hearing problems, terminal illness or severe mental illness); individuals presenting suicidal risk during the two weeks prior to the screening assessment, as assessed by the 9th item of the PHQ-9 and Immediate Suicide Risk Protocol.

Design outcomes

Primary

Measure	Time frame
The proportion of participants recovered (PHQ-9<10) from depression, assessed with the 9-item Patient Health Questionnaire (PHQ-9) at three months after inclusion in the trial.	—

Secondary

Measure	Time frame
The proportion recovered at five months (PHQ-9<10) will assess the maintenance of any earlier clinical gains. The continuous score of the PHQ-9 will also be considered at three and five months. The following additional secondary measures will be completed at three and five months: general quality of life using the 5-item EuroQol (EQ-5D-5L), ICEpop CAPability measure for Older people (ICECAP-O), generalized Anxiety Disorder 7-item scale (GAD-7) and three-item UCLA Loneliness scale (3-item UCLA).	—

Measure

Time frame

The proportion recovered at five months (PHQ-9<10) will assess the maintenance of any earlier clinical gains. The continuous score of the PHQ-9 will also be considered at three and five months. The following additional secondary measures will be completed at three and five months: general quality of life using the 5-item EuroQol (EQ-5D-5L), ICEpop CAPability measure for Older people (ICECAP-O), generalized Anxiety Disorder 7-item scale (GAD-7) and three-item UCLA Loneliness scale (3-item UCLA).

—

Countries

Brazil

Contacts

Public ContactMarcia Scazufca

scazufca@usp.br+551126617268

Outcome results

None listed